Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders and its different therapeutic areas. With more than 850 professionals, Neuraxpharm has a unique understanding of the CNS market built over 35 years. We have a direct presence in Germany, Spain, France, Italy, Czech Republic, Poland, Austria, Switzerland, Slovakia, United Kingdom, Hungary, Portugal and Switzerland with plans of further geographic expansion as part of our strategy to strengthen our position as a European leader in CNS treatments.

With more than 130 molecules, Neuraxpharm has one of the largest drug portfolios of CNS treatment options that has been strategically developed to meet the needs of all CNS patients.

Through our International Trade Business (ITB) department we work with companies on a B2B basis to provide products to more than 50 countries. Our rich portfolio and pipeline is available available for partnering outside our own markets. 

Neuraxpharm also has its own manufacturing site for Finished Dosage Forms (FDF) called Lesvi and located in Spain.

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Meet us at

CPhI Festival of Pharma

5 - 16 October 2020

View Our Exhibitor Profile

Contact information




View All Contact Info

Top Products


Laboratorios Lesvi S.L.

Request Info


Laboratorios Lesvi S.L.

Request Info

Our Resources

Categories affiliated with Laboratorios Lesvi S.L.